Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.3.1.900
Consolidated Statements of Operations - USD ($)
12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Income Statement [Abstract]    
Collaboration revenue $ 648,382  
Operating expenses:    
Research and development 5,888,659 $ 1,255,535
General and administrative 3,613,416 1,391,638
Total operating expenses 9,502,075 2,647,173
Operating loss (8,853,693) (2,647,173)
Other income (expense):    
Interest expense (2,440) (24,021)
Interest income 3,417 2,115
Forgiveness of interest on note payable   7,466
Gain on the settlement of debt   145,006
Change in fair value of warrant liability   (28,448)
Foreign currency exchange gain 1,977 4,570
Other income, net 2,954 106,688
Net loss $ (8,850,739) $ (2,540,485)
Net loss per share, basic and diluted $ (0.28) $ (0.13)
Weighted average number of common shares outstanding, basic and diluted 31,350,145 20,159,861